Blue Sail Medical: Blue Sail Group's shareholding ratio has dropped to 10.96%

Blue Sail Medical Announcement: In accordance with disclosure obligations, Blue Sail Group's equity holding in Blue Sail Medical has been diluted from 98% to 47.0013% due to an additional investment by Shandong Langhui. This change has resulted in Shandong Langhui becoming the indirect controlling shareholder of Blue Sail Medical, replacing Blue Sail Group. Blue Sail Group's shareholding in Blue Sail Medical has decreased from 23.31% to 10.96%. This equity change does not involve any share transactions, and Blue Sail Group currently has no plans to increase or decrease its holdings in the next 12 months.